Lexaria Bioscience Corp. (NASDAQ: LEXX) Delighted About Well-Received DehydraTECH-CBD Proposals by the FDA; Maintains Late 2022/Early 2023 Target For Complete IND Application

August 19, 2022

Today’s Stock Market in 2-Minutes

April 25, 2024
Cyngn Announces Closing of $5.0 Million Firm Commitment Public Offering of Common Stock

April 25, 2024
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

April 25, 2024
Byrna Technologies Promotes John Brasseur to Chief Operating Officer and Raises Production Target to 18,000 Launchers per Month

April 25, 2024